AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie scope 1 & 2 Market-Based GHG Intensity (tCO2e/$M revenue)
AbbVie ESG Action Reports
Latest, FY2025
6.23
Period ended Dec 31, 2025
Change on a year earlier
-16.9%
7.50 in FY2024
History
5 years
Since FY2021
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 1 & 2 Market-Based GHG Intensity (tCO2e/$M revenue) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.23 | -16.9% | AbbVie 2025 ESG Action Report ↗ |
| FY2024 | Dec 31, 2024 | 7.50 | -11.3% | AbbVie 2025 ESG Action Report ↗ |
| FY2023 | Dec 31, 2023 | 8.46 | -6.8% | AbbVie 2025 ESG Action Report ↗ |
| FY2022 | Dec 31, 2022 | 9.08 | -18.3% | AbbVie 2023 ESG Action Report ↗ |
| FY2021 | Dec 31, 2021 | 11.12 | – | AbbVie 2023 ESG Action Report ↗ |
Cite this data
StockData. (2026). AbbVie Scope 1 & 2 Market-Based GHG Intensity (tCO2e/$M revenue), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg_ghg_intensity
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.